%0 Journal Article
%T New Technologies To Enhance In Vivo Reprogramming for Regenerative Medicine
%J -
%D 2019
%R https://doi.org/10.1016/j.tibtech.2018.11.003
%X CRISPR/Cas9 gene-editing systems have been reengineered as programmable transcription factors that can target nearly any gene sequence. A single effector can modulate the expression levels of multiple genes and include epigenetic modifiers
%U https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(18)30313-5